[{"Assets_0_Q1_USD":"6862914000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"29.03","EarningsPerShareDiluted_1_Q1_USD":"28.74","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"42943000.0","NetIncomeLossConverted_1_Q1_USD":"865195000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q1_USD":"553979000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q1_USD":"4863855000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"30104000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"29801000.0","filed":"20190510","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"BIO-RAD LABORATORIES, INC.","period":"20190331","qtrs":"0","uom":"USD"}]